e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
No added value of interferon-gamma release to a prediction model for childhood tuberculosis
Togun Toyin O., Egere Uzochukwu, Gomez Marie P., Sillah Abdou K., Daramy Mohammed, Tientcheu Leopold D., S. Sutherland Jayne, Hill Philip C., Kampmann Beate
Source:
Eur Respir J 2016; 47: 223-232
Journal Issue:
January
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Togun Toyin O., Egere Uzochukwu, Gomez Marie P., Sillah Abdou K., Daramy Mohammed, Tientcheu Leopold D., S. Sutherland Jayne, Hill Philip C., Kampmann Beate. No added value of interferon-gamma release to a prediction model for childhood tuberculosis. Eur Respir J 2016; 47: 223-232
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Persistent fever and cytopenia in a patient with pulmonary tuberculosis
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
Source: Eur Respir J 2008; 32: 1607-1615
Year: 2008
Do kinetics of interferon-gamma responses predict TB relapse?
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
A comparison of the accuracy of IP-10 and IFN-γ for the diagnosis of TB
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009
The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant candidates
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Serial interferon-gamma release assay in children with tuberculosis infection
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007
Time interval to conversion of interferon-? release assay after exposure to tuberculosis
Source: Eur Respir J 2011; 37: 1447-1452
Year: 2011
Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection
Source: Eur Respir J 2013; 41: 644-648
Year: 2013
IFN-gamma production in response to RD1 assays correlate with TST size and with the frequency of exposure to the index case in contacts recently exposed to
mycobacterium tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Interferon-gamma release assays for diagnosis of active pleural tuberculosis: a developing world perspective
Source: Eur Respir J 2011; 38: 747-748
Year: 2011
Interferon-gamma release assays for diagnosis of active pleural tuberculosis: a developing world perspective
Source: Eur Respir J 2011; 38: 746
Year: 2011
Comparative study of the usefulness of TST and three interferon-gamma release assasys (IGRAs) for the differential diagnosis of pulmonary tuberculosis
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Support of ex vivo IFN-gamma release assays in the diagnosis of tuberculosis infection in HIV/AIDS patients
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011
Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis
Source: Eur Respir J 2007; 30: 722-728
Year: 2007
Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)?
Source: International Congress 2018 – Important changes in the management of tuberculosis
Year: 2018
The role of interferon-gamma release assays for the diagnosis of tuberculosis
Source: Annual Congress 2011 - TBNET: tuberculosis research in Europe
Year: 2011
Distinction tuberculosis from
Mycobacterium avium
complex disease using interferon-gamma release assay
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept